NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Gary, if they’re forming a spin-off of sorts, that would explain any lack of movement in terms of staffing or governance, which is what’s thrown me off for a year. Forming a new company means new management, staffing, directors and addressing various resource related matters.

Might also be a reason for why there’s so much attention devoted to Advent, but very little information or progress on the CRL/Cognate contract.

But none of that would be public information or otherwise announced since it’s not happening at NWBO. Moreover, this might explain adding a second listing advisor for guidance since the newco would likely become a public company,

Another problem this would solve, by selling or dissolving NWBO, that gets rid of a company with serious reputational problems. Better to start over again.

If this is the direction where everything is headed, it’s an awfully complicated transaction.